Seminars in Roentgenology
Volume 41, Issue 2 , Pages 139-149 , April 2006

Prostate Cancer Imaging

  • Vikas Kundra, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Vikas Kundra, MD, PhD, Director of Molecular Imaging, Department of Radiology, Department of Experimental Diagnostic Imaging, The University of Texas, M. D. Anderson Cancer Center, Division of Diagnostic Imaging, Box 57, 1515 Holcombe Blvd., Houston, Texas 77030.

References 

  1. Cancer Facts & Figures, 2005. Atlanta, GA. American Cancer Society; 2005. Available at: http://www.cancer.org/docroot/STT/content/STT1xCancerFactsFigures2005.asp
  2. McNeal JE , Redwine EA , Freiha FS , et al.   Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread . Am J Surg Pathol . 1988;12(12):897–906
  3. Clements R . The role of transrectal ultrasound in diagnosing prostate cancer . Curr Urol Rep . 2002;3(3):194–200
  4. Makarov DV , Sanderson H , Partin AW , et al.   Gleason score 7 prostate cancer on needle biopsy (is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?) . J Urol . 2002;167(6):2440–2442
  5. Catalona WJ , Smith DS . 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer . J Urol . 1994;152(5 Pt. 2):1837–1842
  6. Gerber GS , Thisted RA , Scardino PT , et al.   Results of radical prostatectomy in men with clinically localized prostate cancer . JAMA . 1996;276(8):615–619
  7. Catalona WJ , Hudson MA , Scardino PT , et al.   Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer (receiver operating characteristic curves) . J Urol . 1994;152(6 Pt. 1):2037–2042
  8. Catalona WJ , Smith DS , Ornstein DK . Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements . JAMA . 1997;277(18):1452–1455
  9. Gretzer MB , Partin AW . PSA markers in prostate cancer detection . Urol Clin North Am . 2003;30(4):677–686
  10. Partin AW , Mangold LA , Lamm DM , et al.   Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium . Urology . 2001;58(6):843–848
  11. Keetch DW , Catalona WJ , Smith DS . Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values . J Urol . 1994;151(6):1571–1574
  12. Roehrborn CG , Pickens GJ , Sanders JS . Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels . Urology . 1996;47(3):347–352
  13. Ellis WJ , Brawer MK . Repeat prostate needle biopsy (who needs it?) . J Urol . 1995;153(5):1496–1498
  14. Presti JC , Chang JJ , Bhargava V , et al.   The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies (results of a prospective clinical trial) . J Urol . 2000;163(1):163–166 discussion 166-167
  15. Spencer J , Golding S . CT evaluation of lymph node status at presentation of prostatic carcinoma . Br J Radiol . 1992;65(771):199–201
  16. Saitoh H , Yoshida K , Uchijima Y , et al.   Two different lymph node metastatic patterns of a prostatic cancer . Cancer . 1990;65(8):1843–1846
  17. Vinnicombe SJ , Norman AR , Nicolson V , et al.   Normal pelvic lymph nodes (evaluation with CT after bipedal lymphangiography) . Radiology . 1995;194(2):349–355
  18. Oyen RH , Van Poppel HP , Ameye FE , et al.   Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy (prospective study of 285 patients) . Radiology . 1994;190(2):315–322
  19. Nishijima Y , Uchida K , Koiso K , et al.   Clinical significance of the vertebral vein in prostate cancer metastasis . Adv Exp Med Biol . 1992;324:93–100
  20. Bubendorf L , Schopfer A , Wagner U , et al.   Metastatic patterns of prostate cancer (an autopsy study of 1,589 patients) . Hum Pathol . 2000;31(5):578–583
  21. Yu KK , Hawkins RA . The prostate (diagnostic evaluation of metastatic disease) . Radiol Clin North Am . 2000;38(1):139–157
  22. Jewett HJ . Significance of the palpable prostatic nodule . J Am Med Assoc . 1956;160(10):838–839
  23. Smith DS , Catalona WJ . Interexaminer variability of digital rectal examination in detecting prostate cancer . Urology . 1995;45(1):70–74
  24. Dahnert WF , Hamper UM , Eggleston JC , et al.   Prostatic evaluation by transrectal sonography with histopathologic correlation (the echopenic appearance of early carcinoma) . Radiology . 1986;158(1):97–102
  25. Griffiths GJ , Clements R , Jones DR , et al.   The ultrasound appearances of prostatic cancer with histological correlation . Clin Radiol . 1987;38(3):219–227
  26. Lee F , Torp-Pedersen S , Littrup PJ , et al.   Hypoechoic lesions of the prostate (clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen) . Radiology . 1989;170(1 Pt. 1):29–32
  27. Rifkin MD , Sudakoff GS , Alexander AA . Prostate (techniques, results, and potential applications of color Doppler US scanning) . Radiology . 1993;186(2):509–513
  28. Newman JS , Bree RL , Rubin JM . Prostate cancer (diagnosis with color Doppler sonography with histologic correlation of each biopsy site) . Radiology . 1995;195(1):86–90
  29. Lavoipierre AM , Snow RM , Frydenberg M , et al.   Prostatic cancer (role of color Doppler imaging in transrectal sonography) . AJR Am J Roentgenol . 1998;171(1):205–210
  30. Kuligowska E , Barish MA , Fenlon HM , et al.   Predictors of prostate carcinoma (accuracy of gray-scale and color Doppler US and serum markers) . Radiology . 2001;220(3):757–764
  31. Cheng D , Tempany CM . MR imaging of the prostate and bladder . Semin Ultrasound CT MR . 1998;19(1):67–89
  32. Hricak H , Dooms GC , McNeal JE , et al.   MR imaging of the prostate gland (normal anatomy) . AJR Am J Roentgenol . 1987;148(1):51–58
  33. Hricak H , Dooms GC , Jeffrey RB , et al.   Prostatic carcinoma (staging by clinical assessment, CT, and MR imaging) . Radiology . 1987;162(2):331–336
  34. Schiebler ML , Schnall MD , Pollack HM , et al.   Current role of MR imaging in the staging of adenocarcinoma of the prostate . Radiology . 1993;189(2):339–352
  35. Ikonen S , Kivisaari L , Vehmas T , et al.   Optimal timing of post-biopsy MR imaging of the prostate . Acta Radiol . 2001;42(1):70–73
  36. Jager GJ , Ruijter ET , van de Kaa CA , et al.   Local staging of prostate cancer with endorectal MR imaging (correlation with histopathology) . AJR Am J Roentgenol . 1996;166(4):845–852
  37. Hering F , Rist M , Roth J , et al.   Does microinvasion of the capsule and/or micrometastases in regional lymph nodes influence disease-free survival after radical prostatectomy? . Br J Urol . 1990;66(2):177–181
  38. Yu KK , Hricak H , Alagappan R , et al.   Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging (multivariate feature analysis) . Radiology . 1997;202(3):697–702
  39. Lange PH , Narayan P . Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy . Urology . 1983;21(2):113–118
  40. Harisinghani MG , Barentsz J , Hahn PF , et al.   Noninvasive detection of clinically occult lymph-node metastases in prostate cancer . N Engl J Med . 2003;348(25):2491–2499
  41. Keller TM , Michel SC , Frohlich J , et al.   USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors (preliminary results) . Eur Radiol . 2004;14(6):937–944
  42. Sigal R , Vogl T , Casselman J , et al.   Lymph node metastases from head and neck squamous cell carcinoma (MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR)—results of a phase-III multicenter clinical trial) . Eur Radiol . 2002;12(5):1104–1113
  43. Rahmouni A , Yang A , Tempany CM , et al.   Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography . J Comput Assist Tomogr . 1992;16(6):935–940
  44. al-Rimawi M , Griffiths DJ , Boake RC , et al.   Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostatic volume . Br J Urol . 1994;74(5):596–600
  45. Ikonen S , Kivisaari L , Tervahartiala P , et al.   Prostatic MR imaging. Accuracy in differentiating cancer from other prostatic disorders . Acta Radiol . 2001;42(4):348–354
  46. Swindle P , McCredie S , Russell P , et al.   Pathologic characterization of human prostate tissue with proton MR spectroscopy . Radiology . 2003;228(1):144–151
  47. Scheidler J , Hricak H , Vigneron DB , et al.   Prostate cancer (localization with three-dimensional proton MR spectroscopic imaging—clinicopathologic study) . Radiology . 1999;213(2):473–480
  48. Coakley FV , Qayyum A , Kurhanewicz J . Magnetic resonance imaging and spectroscopic imaging of prostate cancer . J Urol . 2003;170(6 Pt. 2):S69–S75 discussion S75-S76
  49. Algra PR , Bloem JL , Tissing H , et al.   Detection of vertebral metastases (comparison between MR imaging and bone scintigraphy) . Radiographics . 1991;11(2):219–232
  50. Taoka T , Mayr NA , Lee HJ , et al.   Factors influencing visualization of vertebral metastases on MR imaging versus bone scintigraphy . AJR Am J Roentgenol . 2001;176(6):1525–1530
  51. Gold RI , Seeger LL , Bassett LW , et al.   An integrated approach to the evaluation of metastatic bone disease . Radiol Clin North Am . 1990;28(2):471–483
  52. Haukaas S , Roervik J , Halvorsen OJ , et al.   When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer? . Br J Urol . 1997;79(5):770–776
  53. Manyak MJ , Hinkle GH , Olsen JO , et al.   Immunoscintigraphy with indium-111-capromab pendetide (evaluation before definitive therapy in patients with prostate cancer) . Urology . 1999;54(6):1058–1063
  54. Ponsky LE , Cherullo EE , Starkey R , et al.   Evaluation of preoperative ProstaScint scans in the prediction of nodal disease . Prostate Cancer Prostatic Dis . 2002;5(2):132–135
  55. Raj GV , Partin AW , Polascik TJ . Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy . Cancer . 2002;94(4):987–996
  56. Sodee DB , Malguria N , Faulhaber P , et al.   Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer. The ProstaScint Imaging Centers . Urology . 2000;56(6):988–993
  57. Ellis RJ , Kim EY , Conant R , et al.   Radioimmunoguided imaging of prostate cancer foci with histopathological correlation . Int J Radiat Oncol Biol Phys . 2001;49(5):1281–1286
  58. Yao D , Trabulsi EJ , Kostakoglu L , et al.   The utility of monoclonal antibodies in the imaging of prostate cancer . Semin Urol Oncol . 2002;20(3):211–218
  59. Kwee SA , Coel MN , Lim J , et al.   Prostate cancer localization with 18fluorine fluorocholine positron emission tomography . J Urol . 2005;173(1):252–255
  60. Swindle PW , Kattan MW , Scardino PT . Markers and meaning of primary treatment failure . Urol Clin North Am . 2003;30(2):377–401
  61. Pucar D , Shukla-Dave A , Hricak H , et al.   Prostate cancer (correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience) . Radiology . 2005;236(2):545–553
  62. Manzone TA , Malkowicz SB , Tomaszewski JE , et al.   Use of endorectal MR imaging to predict prostate carcinoma recurrence after radical prostatectomy . Radiology . 1998;209(2):537–542
  63. Silverman JM , Krebs TL . MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy . AJR Am J Roentgenol . 1997;168(2):379–385

PII: S0037-198X(06)00008-3

doi: 10.1053/j.ro.2006.03.001

Seminars in Roentgenology
Volume 41, Issue 2 , Pages 139-149 , April 2006

Article Tools

* Image Usage & Resolution